Los Angeles Capital Management LLC Entrada Therapeutics, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.2 Billion
- Q4 2024
A detailed history of Los Angeles Capital Management LLC transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 28,032 shares of TRDA stock, worth $377,871. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,032
Previous 33,932
17.39%
Holding current value
$377,871
Previous $542,000
10.7%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TRDA
# of Institutions
103Shares Held
28.2MCall Options Held
34.5KPut Options Held
16.4K-
Baker Bros. Advisors LP New York, NY4.87MShares$65.6 Million0.83% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.43MShares$59.7 Million48.7% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$59.4 Million28.09% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.05MShares$41.1 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.71MShares$23.1 Million0.01% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $423M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...